Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
Clinical trial NCT00364143 · COMPLETED
Trial details
- NCT number
- NCT00364143
- Sponsor
- Yakult Honsha Co., LTD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.